T. Rowe Price Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $454K | Buy |
|
|||||
|
2024
Q3 | $380K | Buy |
|
|||||
|
2024
Q2 | $236K | Buy |
|
|||||
|
2024
Q1 | $204K | Buy |
|
|||||
|
2023
Q4 | $187K | Buy |
|
|||||
|
2023
Q3 | $247K | Buy |
|
|||||
|
2023
Q2 | $346K | Buy |
|
|||||
|
2023
Q1 | $448K | Buy |
|
|||||
|
2022
Q4 | $319K | Buy |
|
|||||
|
2022
Q3 | $424K | Buy |
|
|||||
|
2022
Q2 | $279K | Buy |
|
|||||
|
2022
Q1 | $364K | Buy |
|
|||||
|
2021
Q4 | $480K | Buy |
|